Results 101 to 110 of about 791 (161)

Research progress on chimeric antigen receptor-based immunotherapy against autoimmune diseases. [PDF]

Hum Vaccin Immunother
Jiang M, Zhao J, Yuan J, Yu Z, Liu J, Zhu Z, Ning X, Sun S.   +7 more
europepmc   +1 more source

CAR-based cell therapy for autoimmune diseases. [PDF]

Front Immunol
Li X, He C, Wang K, Xu GY, Xie YC, Ying XY.   +5 more
europepmc   +1 more source

Current advancements in cellular immunotherapy for autoimmune disease. [PDF]

Semin Immunopathol
Berry CT, Frazee CS, Herman PJ, Chen S, Chen A, Kuo Y, Ellebrecht CT.   +6 more
europepmc   +1 more source

Is the Structure of ADHD stable across adulthood? Insights from the CAARS 2

Psychiatry Research
Heather Clark, Drew Erhardt, Elizabeth Sparrow, Joanna Solomon   +3 more
openaire   +1 more source

How does the Vietnamese stock market react when the Fed gives an announcement in time at the zero lower bound? [PDF]

Heliyon
Ngo N, Nguyen H, Nguyen Y, Le S.
europepmc   +1 more source

CAR T-cells meet autoimmune neurological diseases: a new dawn for therapy. [PDF]

Front Immunol
Chinas NA, Alexopoulos H.
europepmc   +1 more source

Advances in B Cell Targeting for Treating Muscle-Specific Tyrosine Kinase-Associated Myasthenia Gravis. [PDF]

Immunotargets Ther
Hu G, Zhao X, Wang Y, Zhu X, Sun Z, Yu X, Wang J, Liu Q, Zhang J, Zhang Y, Yang J, Chang T, Ruan Z, Lv J, Gao F.   +14 more
europepmc   +1 more source

CAR-engineered T cell therapy as an emerging strategy for treating autoimmune diseases. [PDF]

Front Med (Lausanne)
Vukovic J, Abazovic D, Vucetic D, Medenica S.   +3 more
europepmc   +1 more source

Immunological Targets in Generalized Myasthenia Gravis Treatment: Where Are We Going Now? [PDF]

Brain Sci
Rossini E, Leonardi L, Morino S, Antonini G, Fionda L.   +4 more
europepmc   +1 more source

Assessing the impact of extreme climate events on the global renewable energy market. [PDF]

iScience
Shen S, Xiang L.
europepmc   +1 more source